53 results
Medicine
European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter
Authorisation status
Refused Remove Refused filter
-
List item
Human medicine European public assessment report (EPAR): Istodax
romidepsin, Lymphoma, Non-Hodgkin
Date of refusal: 12/02/2013,
, Refused, Last updated: 14/03/2013
-
List item
Human medicine European public assessment report (EPAR): Balaxur
memantine hydrochloride, donepezil hydrochloride, Alzheimer Disease
Date of refusal: 20/02/2013, Refused, Last updated: 11/03/2013 -
List item
Human medicine European public assessment report (EPAR): Acrescent
memantine hydrochloride, donepezil hydrochloride, Alzheimer Disease
Date of refusal: 20/02/2013, Refused, Last updated: 11/03/2013 -
List item
Human medicine European public assessment report (EPAR): Elelyso
Taliglucerase alfa, Gaucher Disease
Date of refusal: 25/10/2012,, Refused, Last updated: 23/11/2012
-
List item
Human medicine European public assessment report (EPAR): Folotyn
Pralatrexate, Lymphoma, T-Cell
Date of refusal: 21/06/2012,, Refused, Last updated: 11/07/2012
-
List item
Human medicine European public assessment report (EPAR): Sumatriptan Galpharm
sumatriptan succinate, Migraine Disorders
Date of refusal: 09/02/2012,
, Refused, Last updated: 16/02/2012
-
List item
Human medicine European public assessment report (EPAR): Zeftera (previously Zevtera)
ceftobiprole medocaril, Skin Diseases, Infectious, Soft Tissue Infections
Date of refusal: 16/09/2010, Refused, Last updated: 22/09/2010 -
List item
Human medicine European public assessment report (EPAR): Impulsor
milnacipran, Fibromyalgia
Date of refusal: 08/04/2010, Refused, Last updated: 26/04/2010 -
List item
Human medicine European public assessment report (EPAR): Milnacipran Pierre Fabre Medicament
milnacipran, Fibromyalgia
Date of refusal: 08/04/2010, Refused, Last updated: 26/04/2010 -
List item
Human medicine European public assessment report (EPAR): Sovrima
idebenone, Friedreich Ataxia
Date of refusal: 27/04/2009,, Refused, Last updated: 31/12/2009
-
List item
Human medicine European public assessment report (EPAR): Zelnorm
tegaserod, Irritable Bowel Syndrome
Date of refusal: 19/05/2006, Refused, Last updated: 31/12/2009 -
List item
Human medicine European public assessment report (EPAR): Rhucin
recombinant human C1 inhibitor, Angioedema
Date of refusal: 22/05/2008, Refused, Last updated: 31/12/2009 -
List item
Human medicine European public assessment report (EPAR): Genasense
oblimersen, Melanoma
Date of refusal: 15/10/2007, Refused, Last updated: 31/12/2009 -
List item
Human medicine European public assessment report (EPAR): Gemesis
becaplermin, Guided Tissue Regeneration, Periodontal
Date of refusal: 29/01/2010, Refused, Last updated: 20/11/2009 -
List item
Human medicine European public assessment report (EPAR): Cimzia
Certolizumab pegol, Crohn Disease
Date of refusal: 21/05/2008, Refused, Last updated: 20/03/2008 -
List item
Human medicine European public assessment report (EPAR): Natalizumab Elan Pharma
natalizumab, Crohn Disease
Date of refusal: 11/01/2008, Refused, Last updated: 25/01/2008 -
List item
Human medicine European public assessment report (EPAR): Mylotarg
gemtuzumab ozogamicin, Leukemia, Myeloid, Acute
Date of refusal: 14/04/2008,, Refused, Last updated: 24/01/2008
-
List item
Human medicine European public assessment report (EPAR): Mycograb
recombinant human monoclonal antibody to hsp, Candidiasis
Date of refusal: 22/05/2007, Refused, Last updated: 21/03/2007 -
List item
Veterinary medicine European public assessment report (EPAR): Veraflox
pradofloxacin, Dogs
Date of refusal: 11/12/2006, Refused, Last updated: 24/01/2007 -
List item
Human medicine European public assessment report (EPAR): Thymanax
Agomelatine, Depressive Disorder, Major
Date of refusal: 16/01/2007, Refused, Last updated: 27/07/2006 -
List item
Human medicine European public assessment report (EPAR): Valdoxan
Agomelatine, Depressive Disorder, Major
Date of refusal: 16/01/2007, Refused, Last updated: 27/07/2006 -
List item
Human medicine European public assessment report (EPAR): Alpheon
recombinant human interferon alfa-2a, Hepatitis C, Chronic
Date of refusal: 05/09/2006,
, Refused, Last updated: 28/06/2006
-
List item
Human medicine European public assessment report (EPAR): Yondelis
trabectedin, Sarcoma
Date of refusal: 07/09/2004, Refused, Last updated: 20/11/2003 -
List item
Veterinary medicine European public assessment report (EPAR): Horse Allo 20
allogeneic equine adipose-derived mesenchymal stem cells, Horses
Date of refusal: 13/05/2019, Refused, Last updated: 12/09/2019 -
List item
Human medicine European public assessment report (EPAR): Exondys
eteplirsen, Muscular Dystrophy, Duchenne
Date of refusal: 06/12/2018,, Refused, Last updated: 12/12/2018